Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
ACS Medicinal Chemistry Letters2014Vol. 5(2), pp. 205–209
Citations Over TimeTop 10% of 2014 papers
Ramzi F. Sweis, Marina Pliushchev, Peter J. Brown, Jun Guo, Fengling Li, David Maag, Andrew M. Petros, Nirupama B. Soni, Chris Tse, Masoud Vedadi, Michael R. Michaelides, Gary G. Chiang, William N. Pappano
Abstract
G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.
Related Papers
- → WDR5 Associates with Histone H3 Methylated at K4 and Is Essential for H3 K4 Methylation and Vertebrate Development(2005)814 cited
- → Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3(2005)545 cited
- → Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function(2018)193 cited
- → Development and Implementation of a High-Throughput AlphaLISA Assay for Identifying Inhibitors of EZH2 Methyltransferase(2013)21 cited
- → The Interaction between Histone Lysine Methyltransferase GLP and EZH2(2023)